Carisma Therapeutics Inc.
CARMDelisted Dec 15, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001485003
Carisma Therapeutics Inc. was delisted on Dec 15, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 33 institutions reported holding it in 13F filings for Q3 2025, worth $842.6K in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Carisma Therapeutics Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Carisma Therapeutics Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Klichinsky Michael | Chief Scientific Officer | 0 | Oct 8, 2025 | 2 |
| Kelly Steven | President and CEO | – | Jan 30, 2025 | 0 |
| Cheng Sohanya Roshan | Director | – | Nov 1, 2024 | 0 |
| Scadden David | Director | – | Jul 1, 2024 | 0 |
| Thorell Marella | Director | – | Jul 1, 2024 | 0 |
| Zweifach Sanford S | Director | 413 | Jun 27, 2024 | 0 |
| Morrison Briggs | Director | 12,175 | Jun 27, 2024 | 0 |
| Hohneker John | Director | – | Jun 27, 2024 | 0 |
| Torok Michael | Director | 50,000Indirect | Jun 27, 2024 | 0 |
| Morris Richard Steven | Chief Financial Officer | – | Jun 18, 2024 | 0 |
| Ugwumba Chidozie | Director | 2,215,877Indirect | Jun 8, 2023 | 0 |
| Hodits Regina | Director | 2,297,546Indirect | Mar 9, 2023 | 0 |
| Sullivan Mark | General Counsel & Secretary | 378,651 | Mar 6, 2023 | 0 |
| Cannell Thomas R | President and CEO | 672,386 | Mar 6, 2023 | 0 |
| Forbes Monica | Chief Financial Officer | 505,664 | Mar 6, 2023 | 0 |
| MacDonald Glen C | Chief Technology Officer | 398,918 | Mar 6, 2023 | 0 |
| Ryu Elly | Principal Accounting Officer | 148,624 | Mar 6, 2023 | 0 |
| Honig Peter | Director | 40,000 | Jun 24, 2022 | 0 |
| Duker Jay S. | Director | 40,000 | Jun 24, 2022 | 0 |
| Bourdow Carrie L. | Director | 40,000 | Jun 24, 2022 | 0 |
| Keyes Jason A | Director | 40,000 | Jun 24, 2022 | 0 |
| Jewett Michael A. S. | Director | 40,000 | Jun 24, 2022 | 0 |
| Rosales Minori | Chief Development Officer | – | Jan 26, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2025 (view filing)4:16 PM ET | Oct 7 | 1 day | Klichinsky MichaelChief Scientific Officer | SSale | −57.0K | $0.2542 | −$14.5K | −100.0%0 after | |
| Oct 3, 2025 (view filing)5:25 PM ET | Oct 1-3 | 2 days | Klichinsky MichaelChief Scientific Officer | SSale | −484.3K | $0.2567 | −$124.3K | −100.0%0 after | 3 lots |
| Mar 6, 2023 (view filing) | Mar 2 | 4 days | Sullivan MarkGeneral Counsel & Secretary | SSale | −219.2K | $0.59 | −$129.3K | −36.7%378.7K after | 3 lots |
| Mar 6, 2023 (view filing) | Mar 2 | 4 days | MacDonald Glen CChief Technology Officer | SSale | −170.4K | $0.59 | −$100.5K | −29.9%398.9K after | 3 lots |
| Mar 6, 2023 (view filing) | Mar 2 | 4 days | Ryu EllyPrincipal Accounting Officer | SSale | −17.3K | $0.59 | −$10.2K | −10.4%148.6K after | |
| Mar 6, 2023 (view filing) | Mar 2 | 4 days | Cannell Thomas RPresident and CEO | SSale | −487.5K | $0.59 | −$287.6K | −42.0%672.4K after | 2 lots |
| Mar 6, 2023 (view filing) | Mar 2 | 4 days | Forbes MonicaChief Financial Officer | SSale | −345.8K | $0.59 | −$204.1K | −40.6%505.7K after | 3 lots |
| Feb 23, 2023 (view filing) | Feb 21 | 2 days | Sullivan MarkGeneral Counsel & Secretary | SSale | −39.8K | $0.59 | −$23.5K | −11.7%299.7K after | |
| Feb 23, 2023 (view filing) | Feb 21 | 2 days | Ryu EllyPrincipal Accounting Officer | SSale | −7.16K | $0.59 | −$4.22K | −4.1%165.9K after | |
| Feb 23, 2023 (view filing) | Feb 21 | 2 days | Cannell Thomas RPresident and CEO | SSale | −53.7K | $0.59 | −$31.7K | −8.9%553.1K after | |
| Feb 23, 2023 (view filing) | Feb 21 | 2 days | Forbes MonicaChief Financial Officer | SSale | −61.9K | $0.59 | −$36.5K | −11.4%480.4K after | |
| Feb 23, 2023 (view filing) | Feb 21 | 2 days | MacDonald Glen CChief Technology Officer | SSale | −25.9K | $0.59 | −$15.3K | −8.4%283.0K after |